Therefore, we first checked the genetic alterations of CDH1, CCL11, HLA–DRA, NOS2, NAT2, TIMP1 and TP53 in CRC patients, in TCGA cohorts via the cBioPortal online tool. This evidence concerns the gene NOS2 and colorectal carcinoma.